AT&T Seeks Shareholder Approval for New Incentive Plans and Officer Exculpation

summarizeSummary

AT&T is seeking shareholder approval for new equity incentive and deferral plans totaling 190 million shares in potential dilution, alongside a proposal to exculpate officers from certain liabilities.

check_boxKey Events

• Proposed 2026 Incentive Plan

  Shareholders will vote on a new 2026 Incentive Plan, authorizing the issuance of up to 130 million shares for equity and cash awards to eligible employees, replacing the 2018 plan.

• Amended Stock Purchase and Deferral Plan (SPDP)

  The company seeks approval to increase the shares authorized for issuance under the SPDP by 60 million, bringing the total to 136 million shares for employee stock purchases and matching contributions.

• Officer Exculpation Proposal

  A proposal to amend the Restated Certificate of Incorporation aims to limit monetary liability for certain officers for breaches of fiduciary duty of care, as permitted by Delaware law.

• Shareholder Proposals

  Two shareholder proposals are included: one regarding the right to act by written consent and another concerning EEO-1 report disclosure, both of which the Board recommends voting against.

auto_awesomeAnalysis

AT&T's preliminary proxy statement outlines several key proposals for its 2026 Annual Meeting. Most notably, the company is seeking shareholder approval for a new 2026 Incentive Plan, authorizing up to 130 million shares, and an amendment to the Stock Purchase and Deferral Plan (SPDP) to increase authorized shares by 60 million. Combined, these proposals represent a potential dilution of approximately 2.72% of current outstanding shares, valued at roughly $5.27 billion based on the current stock price. This is a significant amount of potential dilution, primarily for employee compensation and deferral programs. Additionally, the company proposes an amendment to its Restated Certificate of Incorporation to exculpate certain officers from personal liability for breaches of fiduciary duty of care, a corporate governance change that aligns with recent Delaware law amendments but may be viewed with scrutiny by some shareholders. The filing also includes routine proposals and two shareholder proposals that the Board recommends against, concerning shareholder written consent and EEO-1 report disclosure. The company highlights strong 2025 financial performance and strategic achievements, including substantial cash flow generation and industry-leading Total Shareholder Return, providing a positive backdrop to these capital allocation and governance discussions.